Care | Page 268 of 309 | SpiritIndia.com

Health :: Innocoll – collaguard – a collagen-based advanced wound care product

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has received US 510k approval for CollaGUARD(TM), an advanced wound care product based on Innocoll’s proprietary CollaRx(TM) membrane technology. CollaGUARD is indicated for the management of superficial and deep wounds, including coverage of skin ulcers and temporary dermatoplasty in the case of lesion and burns. CollaGUARD has already received CE-mark approval for marketing in Europe.

Cancer :: Agennix receives fda orphan drug designation for talactoferrin alfa in renal cell carcinoma

Agennix today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company’s oral formulation of Talactoferrin Alfa (talactoferrin or TLF) for the treatment of renal cell carcinoma (RCC). Oral TLF is currently in Phase II clinical development for RCC. Results from a multi-center Phase 2 RCC trial that included six leading U.S. cancer centers were presented at the 2006 Annual meeting of the American Society of Clinical Oncology (ASCO).

Radiography :: Eklin Medical Systems – industry’s first comprehensive digital radiographic positioning guide

Eklin Medical Systems, Inc., a leader in digital radiography (DR), PACS (Picture Archiving and Communication System) and Practice Information Management software (PIMS) for the veterinary care market, announced the introduction of a comprehensive positioning guide for capturing diagnostic equine digital radiographs. The guide features Sheika, a petite gray Arabian mare, who was rescued by the founders of Peninsula Equine Medical Center before she was about to be euthanized by her owner. The 65-page guide provides a quick reference resource for veterinarians and technicians when imaging a horse’s feet, pasterns, fetlocks, stifles, skull, cervical spine and other pertinent anatomy.

Cancer :: Agencourt genomic services is key collaborator in new study on breast and colon cancer genes

Agencourt Bioscience Corporation, a Beckman Coulter company, has announced that its Genomic Services were integral in a breakthrough Johns Hopkins study on the genetic code for breast and colon cancers. A recent and widely publicized report on that study, published this month in Science Express, was co-authored by James Hartigan, an Agencourt project manager. The research identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control. The study provides an understanding into disease processes and is expected to drive cancer research for years to come.

Chikungunya :: Treating after effects of chikungunya

Chikungunya is turning out to be a national epidemic & a major calamity. There are horror stories of whole villages in Rajasthan being affected & old people who are so debilitated that they are not able to feed themselves.

Chikungunya :: Treating chikungunya with Ayurveda, Siddha

While the Allopathic system seems to have no medicine or treatment to cure or prevent the disease, or take care of the after-effects – most importantly severe joint pains – Ayurveda / Siddha Physicians have been routinely treating this fever.

Prostate Cancer :: Obesity independently impacts prostate cancer screening

When interpreting prostate cancer screening test results, physicians should consider the impact of a patient’s body mass index, regardless of race, according to a new study. Published in the November 15, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study found that obese African-American and Caucasian men had lower levels of prostate surface antigen (PSA) and free PSA (fPSA) than men with normal body mass index (BMI), suggesting that an obese man with a slightly elevated PSA may be at higher risk for prostate cancer than a man with normal BMI.

Diabetes :: Vision loss can be prevented in people with diabetes

The millions of Americans afflicted with Type 1 and 2 Diabetes face many potential complications,including: heart and kidney disease; nerve damage and stroke; foot and skin problems; and gastrointestinal disorders and hypoglycemia.

Asthma :: Mutual recognition procedure for Symbicort maintenance n reliever therapy Symbicort smart

AstraZeneca announced that it has successfully completed the European Union Mutual Recognition Procedure (MRP) for Symbicort? Maintenance And Reliever Therapy (Symbicort SMART?). This new asthma treatment approach allows patients to use just one inhaler for both maintenance and relief of asthma symptoms.

Nutrition :: Researchers look to solve mystery behind egcg and probiotics

When talking about nutrition, EGCG and probiotics are two words that we’ve been hearing a lot about these days. But most consumers don’t know what they are, where they are found and what they do. Some of that mystery was cleared up this week at the 47th Annual Symposia of the American College of Nutrition (ACN) where leading nutrition experts revealed new research about the health benefits of these two ingredients.